Akut limfoid leukémia (ALL): vizsgálatok itt: Finnország
13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleInternational Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
- Where
- Helsinki, Kuopio, Oulu, Tampere, Turku
- Életkor
- 1 év to 64 év
- People
- 750 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00 - 2/3. fázisTaking peopleFramework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
- Where
- Helsinki
- Életkor
- 3 hónap to 25 év
- People
- 1000 worldwide
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT07297914 · EU 2025-522052-13-00 - 3. fázisTaking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Helsinki, Kuopio, Oulu, Tampere, Turku
- Életkor
- 1 nap to 1 év
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - 2. fázisTaking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Helsinki
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - 2/3. fázisTaking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Helsinki
- Életkor
- 1 hónap to 18 év
- People
- 1800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - No phaseTaking peopleA Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Where
- Helsinki, Kuopio, Oulu, Tampere, Turku
- Életkor
- 0 év to 45 év
- People
- 500 worldwide
- Run by
- Mats Heyman
See details and how to joinNCT03911128 - 3. fázisTaking peopleA Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Where
- Helsinki, Kuopio, Oulu, Tampere, Turku
- Életkor
- 0 év to 45 év
- People
- 6430 worldwide
- Run by
- Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01 - 1/2. fázisTaking peopleInotuzumab ozogamicin for Acute Lymphoblastic Leukemia
- Where
- Helsinki
- Életkor
- Up to 17 év
- People
- 142 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504694-20-00 · EU 2023-504694-20-00 - 3. fázisTaking peopleStudy on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
- Where
- Helsinki, Kuopio, Oulu, Tampere, Turku
- Életkor
- Up to 64 év
- People
- 87 worldwide
- Run by
- Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00 · EU 2025-520982-39-00 - 2. fázisTaking peopleInternational Study for Treatment of High Risk Childhood Relapsed ALL 2010
- Where
- Helsinki, Kuopio, Oulu, Tampere, Turku
- Életkor
- Up to 17 év
- People
- 250 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00 - 1/2. fázisTaking peopleHEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
- Where
- Helsinki
- Életkor
- 1 év to 21 év
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00 - 1/2. fázisTaking peopleHEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Helsinki
- Életkor
- 1 év to 21 év
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01 - 1/2. fázisTaking peopleHEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Helsinki
- Életkor
- 1 év to 21 év
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00